Tyrosine-kinase inhibitors (TKI) in metastatic kidney cancer (mKC) treatment.

被引：0
|
作者：
Vladimirova, Liubov Yu [1 ]
Kit, Oleg Ivanovich [1 ]
Popova, Irina L. [1 ]
Abramova, Natalya A. [1 ]
机构：
[1] Rostov Sci Res Inst Oncol, Rostov Na Donu, Russia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.e15546
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15546
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Clinical Feature of Cardiotoxicity Induced by Tyrosine-Kinase Inhibitor in Cancer Treatment
    Mukai, Mikio
    JOURNAL OF CARDIAC FAILURE, 2015, 21 (10) : S160 - S160
  • [32] SAFETY AND TOLERABILITY OF TYROSINE KINASE INHIBITORS (TKI) IN HEMODIALYTIC METASTATIC RENAL CELL CARCINOMA PATIENTS
    Sabbatini, Roberto
    Porta, Camillo
    Procopio, Giuseppe
    Gasparro, Donatello
    Ferrari, Alessia
    Pagano, Maria
    Conte, Pier Franco
    ANNALS OF ONCOLOGY, 2009, 20
  • [33] Tyrosine-kinase inhibitors for non-small cell lung cancer - addition - EML
    SELECTION AND USE OF ESSENTIAL MEDICINES: REPORT OF THE WHO EXPERT COMMITTEE ON SELECTION AND USE OF ESSENTIAL MEDICINES, 2019 (INCLUDING THE 21ST WHO MODEL LIST OF ESSENTIAL MEDICINES AND THE 7TH WHO MODEL LIST OF ESSENTIAL MEDICINES FOR CHILDREN), 2019, 1021 : 293 - 301
  • [34] NUTRITIONAL ASSESSMENT AND QUALITY OF LIFE OF ONCOLOGY OUTPATIENTS INITIATING TREATMENT WITH TYROSINE-KINASE INHIBITORS
    Ribed, Almudena
    Romero-Jimenez, Rosa Ma
    Cuerda-Compes, Cristina
    Higuera-Pulgar, Isabel
    Luisa Carrascal-Fabian, Ma
    Escudero-Vilaplana, Vicente
    Angel Arranz-Arija, Jose
    Garcia-Peris, Pilar
    Sanjurjo-Saez, Maria
    NUTRICION HOSPITALARIA, 2014, 30 (05) : 1092 - 1100
  • [35] Small-molecule protein tyrosine kinase inhibitors for the treatment of metastatic prostate cancer
    Gallick, Gary E.
    Corn, Paul G.
    Zurita, Amado J.
    Lin, Sue-Hwa
    FUTURE MEDICINAL CHEMISTRY, 2012, 4 (01) : 107 - 119
  • [36] The role of tyrosine kinase inhibitors in the treatment of HER2+metastatic breast cancer
    Le Du, Fanny
    Dieras, Veronqiue
    Curigliano, Giuseppe
    EUROPEAN JOURNAL OF CANCER, 2021, 154 : 175 - 189
  • [37] Tyrosine-kinase inhibitors to treat radioiodine-refracted, metastatic, or recurred and progressive differentiated thyroid carcinoma
    Ito, Yasuhiro
    Suzuki, Shinichi
    Ito, Ken-ichi
    Imai, Tsuneo
    Okamoto, Takahiro
    Kitano, Hiroya
    Sugitani, Iwao
    Sugino, Kiminori
    Tsutsui, Hidemitsu
    Hara, Hisato
    Yoshida, Akira
    Shimizu, Kazuo
    ENDOCRINE JOURNAL, 2016, 63 (07) : 597 - 602
  • [38] Novel Tyrosine Kinase Inhibitors in the Treatment of Cancer
    Ocana, Alberto
    Serrano, Rosario
    Calero, Raul
    Pandiella, Atanasio
    CURRENT DRUG TARGETS, 2009, 10 (06) : 575 - 576
  • [39] Tyrosine-kinase inhibitors (TKI) in first-line treatment of patients with non-small cell lung cancer (NSCLC) - real life data from the Czech Republic
    Skrickova, Jana
    Chloupkova, Renata
    Bortlicek, Zbynek
    Brabec, Petr
    Hejduk, Karel
    Dusek, Ladislav
    Pesek, Milos
    Kolek, ViTezslav
    Koubkova, Leona
    Cernovska, Marketa
    Salajka, Frantisek
    Zemanova, Milada
    Krejci, Jana
    Coupkova, Helena
    Satankova, Monika
    Benejova, Andrea
    Tomiskova, Marcela
    Roubec, Jaromir
    Grygarkova, Ivona
    Havel, Libor
    Hrnciarik, Michal
    Opalka, Petr
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [40] EGFR tyrosine kinase inhibitors in the treatment of cancer
    Barker, AJ
    MEDICINAL CHEMISTRY INTO THE MILLENNIUM, 2001, (264): : 140 - 147
12345